Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Breast cancer
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Prognosis == * Stage I: 5 year 98.7% survival rate * Overall 5 year survival rate of 90% * Most patients with metastatic disease die of breast cancer * Local recurrence ** Older women with hormone receptor positive cancer: 0.4% per year ** Younger women with triple negative: 1% per year '''Risk profile and associated survival outcomes, MD Anderson validation of biomarkers in TNM 8th edition staging''' {| class="wikitable" | |'''Five-year DSS''' '''(%)''' |'''Univariate analysis''' | |'''Multivariate analysis 2''' | |'''Assigned points''' |- | | |'''HR''' |'''''p''''' |'''HR''' |'''''p''''' | |- |'''Pathological stage''' | | | | | | |- |I |99.1 |Referent | |Referent | |0 |- |IIA |98.0 |2.8 |0.002 |2.3 |0.01 |1 |- |IIB |95.6 |4.8 |<0.0001 |4.0 |<0.0001 |2 |- |IIIA |95.4 |6.8 |<0.0001 |7.2 |<0.0001 |3 |- |IIIC |79.5 |26.6 |<0.0001 |19.9 |<0.0001 |4 |- |'''Nuclear grade''' | | | | | | |- |I |99.8 |Referent | |Referent | |0 |- |II |98.9 |5.0 |0.1 |4.0 |0.2 |0 |- |III |95.3 |25.0 |0.001 |13.1 |0.01 |1 |- |'''ER status''' | | | | | | |- |Positive |98.8 |Referent | |Referent | |0 |- |Negative |92.9 |4.9 |<0.0001 |2.5 |0.001 |1 |- |'''PR status''' | | | | | | |- |Positive |98.8 |Referent | |Referent | | |- |Negative |95.2 |4.0 |<0.0001 | |NS | |- |'''HER2 status''' | | | | | | |- |Positive |97.5 |Referent | |Referent | |0 |- |Negative |98.0 |0.8 |0.5 |2.2 |0.04 |1 |- |'''Factor''' |'''0 points''' | | |'''1 point''' | | |- |Grade |Grade 1/2 | | |Grade 3 | | |- |ER status |ER positive | | |ER negative | | |- |HER2 status |HER2 positive | | |HER2 negative | | |- |'''Stage''' |'''Risk profile''' |'''N''' |'''Five-year DSS''' '''(%)''' |'''95% CI''' |'''Five-year OS''' '''(%)''' |'''95% CI''' |- |I (IA and IB) |0 |36 |100 | |97 |80.4-99.6 |- | |1 |1173 |99.4 |98.7-99.7 |96.7 |95.4-97 |- | |2 |274 |98.8 |96.4-99.6 |94.6 |91-96.8 |- | |3 |119 |96.6 |91.1-98.7 |93.8 |87.5-97 |- |IIA |0 |31 |100 | |96.8 |79.2-99.5 |- | |1 |634 |99.4 |97.5-99.8 |97.1 |94.7-98.4 |- | |2 |236 |97.5 |93.2-99.1 |94.1 |88.7-97 |- | |3 |98 |91 |81.8-95.7 |88.2 |78.5-93.8 |- |IIB |0 |11 |100 | |100 | |- | |1 |309 |96.9 |92.6-98.8 |94.6 |89.6-97.2 |- | |2 |107 |92.9 |83.6-97.1 |89.3 |80.1-94.4 |- | |3 |40 |91.5 |75.6-97.2 |91.5 |75.6-97.2 |- |IIIA |0 |3 |100 | |100 | |- | |1 |134 |98.3 |88.2-99.8 |91.5 |82.6-96 |- | |2 |50 |92.2 |77.2-97.5 |90.3 |75.7-96.3 |- | |3 |7 |68.6 |21.3-91.2 |68.6 |21.3-91.2 |- |IIIC |0 |0 | | | | |- | |1 |39 |92.2 |72.1-98.0 |84.4 |63.7-93.9 |- | |2 |16 |80.8 |51.4-93.4 |80.8 |51.4-93.4 |- | |3 |10 |33.3 |6.3-64.6 |33.3 |6.3-64.6 |} [[Category:Breast]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Breast cancer
(section)
Add topic